期刊文献+

小鼠IL-39的克隆及真核表达载体的构建

Cloning of mouse interleukin-39 and construction of its eukaryotic expression vector
原文传递
导出
摘要 [目的]构建小鼠白介素(interleukin,IL)-39单链融合基因及其真核表达载体。[方法]通过RT-PCR得到小鼠EB病毒诱导基因3(Epstein-Barr virus-induced gene 3,EBI3)及IL-23p19基因的全长编码区。通过重叠延伸PCR和编码疏水性多肽接头(linker)(Gly4Ser)3的DNA序列将小鼠EBI3全长编码区及IL-23p19成熟肽编码区连接起来,构建小鼠IL-39单链融合基因,并将其克隆至真核表达载体pc DNA3.1/V5-His中,通过限制性内切酶双酶切及基因测序鉴定阳性重组载体。[结果]通过重叠延伸PCR得到1 254 bp大小的目的条带,测序分析显示,小鼠IL-39单链融合基因中EBI3、linker和IL-23p19的基因序列及连接顺序和方向均完全正确。[结论]成功构建了小鼠IL-39单链融合基因及其真核表达载体。 [Objective]To construct mouse single chain interleukin-39( IL-39) fusion gene and its eukaryotic expression vector. [Methods]The mouse Epstein-Barr virus-induced gene 3( EBI3) c DNA and IL-23p19 c DNA were amplified by RT-PCR. EBI3 whole coding sequence and IL-23p19 mature peptide coding sequence were fused via a hydrophobic polypeptide linker( Gly4Ser) 3 by overlap extension PCR to obtain mouse single chain IL-39 fusion gene. The mouse single chain IL-39 fusion gene was cloned into eukaryotic expression vector pc DNA3. 1/V5-His and the positive recombinant clone was analyzed by digestion of restriction endonuclease and DNA sequencing. [Results] Overlap extension PCR results showed that1 254 bp target band was obtained. The sequence analysis showed that the sequence,splicing order and orientation of mouse single chain IL-39 fusion gene were completely correct. [Conclusion] The research has successfully constructed the mouse single chain IL-39 fusion gene and its eukaryotic expression vector.
出处 《生物技术》 北大核心 2017年第4期307-311,共5页 Biotechnology
基金 浙江省自然科学基金项目("IL-37调控DC/Treg细胞诱导免疫耐受在支气管哮喘中的作用及分子机制" No.LY17H010001) 浙江省公益技术应用研究项目("IL-38转基因小鼠的建立及在高脂饮食诱导肥胖小鼠模型中的作用" No.2016C37139) 宁波市自然科学基金项目("IL-37抑制博来霉素诱导的小鼠肺纤维化的作用及机制" No.2016A610088)
关键词 小鼠白介素-39 重叠延伸PCR 单链融合基因 真核表达载体 mouse interleukin-39 overlap extension PCR single chain fusion gene eukaryotic expression vector
  • 相关文献

参考文献2

二级参考文献24

  • 1Gee K, Guzzo C, Che Mat NF, et al. The IL-12 family of cytokines in infection, inflammation and autoimmune disorders [J]. Inflamm Allergy Drug Targets, 2009, 8(1):40-52.
  • 2Bettini M, Vignali DA. Regulatory T cells and inhibitory cytokines in autoimmunity[J]. Curr Opin Immunol, 2009, 21 (6):612-618.
  • 3Collison LW, Pillai MR, Chaturvedi V, et al. Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35- and IL-10-dependent manner [J]. J Immunol , 2009, 182 (10): 6121-6128.
  • 4Collison LW, Workman CJ, Kuo TT, et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function [J]. Nature, 2007,450 (7169):566-569.
  • 5Niedbala W, Wei XQ, Cai'B, et al. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Thl7 cells [J]. Eur J Immunol, 2007, 37(11):3021-3029.
  • 6Horton RM, Hunt HD, Ho SN, et al. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension[J]. Gene, 1989, 77(1):61-68.
  • 7Mattner F, Fischer S, Guckes S, et al. The Interleukin-12 subunit p40 specifically inhibits effects of the Interleukin- 12 heterodimer[J]. Eur J Immunol, 1993, 23(9):2202-2208.
  • 8Egwuagu CE, Yu CR, Sun L, et al. Interleukin 35: Criti- cal regulator of immunity and lymphocyte-mediated dis- eases. Cytokine Growth Factor Rev, 2015, 26:587-593.
  • 9Sun L, He C, Nair L, et al. Interleukin 12 (IL-12) family cytokines: Role in immune pathogenesis and treatment of CNS autoimmune disease. Cytokine, 2015, 75:249-255.
  • 10Kastelein RA, Hunter CA, Cua DJ. Discovery and biol- ogy of 1L-23 and IL-27: related but functionally distinct regulators of inflammation. Annu Rev Immunol, 2007, 25: 221-242.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部